India Pharma Conference 2026 to spotlight innovation, global partnerships in New Delhi

Discussions are likely to centre on how the country can move up the pharmaceutical value chain

Bayer sets world record for maternal nutrition advocacy

India continues to face a major maternal nutrition challenge, with nearly 60% of women affected by anaemia and more than 70% experiencing calcium deficiency

India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters

In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga

KIMS Hospitals launches cutting-edge Neurosciences Institute in Mahadevapura

World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk

Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group

Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar

The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline

Practo reports surge in lifestyle disease awareness within Tier 2 cities, led by metabolic health searches

Searches for diabetes, heart conditions, and metabolism-related risks are rising sharply, with Tier 2 cities outpacing metros in specialist consultations

Red Nucleus acquires Bridge Medical Consulting with advisory support from VERTICES PARTNERS

As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm

Dharmendra Singh Gangwar appointed CEO of Rajiv Gandhi Cancer Institute

Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation

Sanofi appoints Dr Parikshit Chaudhari as Head of Market Access & Pricing Strategy

He brings extensive cross-functional expertise built through leadership roles